PSA in drain fluid after prostate removal
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how levels of PSA in the fluid from a drainage tube after prostate removal may help predict the future course of prostate cancer. It may offer insights into recovery and next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated for prostate cancer by having your prostate surgically removed (radical prostatectomy).
- You did not receive hormone therapy or chemotherapy before your surgery.
- You did not have urine leakage after surgery (checked by testing the drainage fluid for creatinine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a test done on the fluid from your surgical drain after prostate removal. It aims to see if changes in that test over time can help predict how well you recover.
This study looks at changes in a marker called PCA3 in the fluid drained from the surgical site after prostate removal. It aims to help predict recovery and cancer outcomes for prostate cancer patients.
This study looks at how PSA (a blood marker) levels measured shortly after prostate removal surgery can predict whether cancer comes back. Researchers hope this helps doctors identify patients who may need closer monitoring or additional treatment after surgery.
This trial tests a PET scan (flotufolastat F 18) to find tiny prostate cancer cells in men whose PSA is very low but still rising after prostate removal. It may help guide further treatment decisions.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.